scispace - formally typeset
K

Keishi Narita

Researcher at University of Yamanashi

Publications -  33
Citations -  1839

Keishi Narita is an academic researcher from University of Yamanashi. The author has contributed to research in topics: Cilium & Motile cilium. The author has an hindex of 20, co-authored 31 publications receiving 1671 citations. Previous affiliations of Keishi Narita include University of Oxford & Toyota.

Papers
More filters
Journal ArticleDOI

Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells

TL;DR: A role for Rab7 and Rab9 in the Golgi targeting of glycosphingolipids is demonstrated and a new therapeutic approach for restoring normal lipid trafficking in NP-C cells is suggested.
Journal ArticleDOI

A Role of the Amino Acid Residue Located on the Fifth Position before the First Aspartate-rich Motif of Farnesyl Diphosphate Synthase on Determination of the Final Product

TL;DR: 20 FPP synthases, each of which has a different amino acid at position 81, are constructed and analyzed, and observations strongly indicate that the amino acid does not come into contact with the substrates but directly contacts the ω-terminal of an elongating allylic product.
Journal ArticleDOI

HSulf-1 Inhibits Angiogenesis and Tumorigenesis In vivo

TL;DR: It is reported that HSulf-1 expression in MDA-MB-468 breast carcinoma clonal lines leads to reduced proliferation in vitro and reduced tumor burden in athymic nude mice in vivo and provides the first evidence of a novel mechanism by which HS sulfur-1 modulates the function of heparan sulfate binding VEGF165 in proliferation and angiogenesis.
Journal ArticleDOI

Genetically encoded calcium indicator illuminates calcium dynamics in primary cilia

TL;DR: Using a genetically encoded calcium indicator targeted to primary cilia, calcium signaling in cilia of mouse fibroblasts and kidney cells upon chemical or mechanical stimulation is visualized with high specificity, high sensitivity and wide dynamic range.
Journal ArticleDOI

Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.

TL;DR: Data indicate that HSulf-1 is epigenetically silenced in ovarian cancer and that epigenetic therapy targeting HS sulfur-1 might sensitize ovarian tumors to conventional first-line therapies.